Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

EMMA
EMMAUS LIFE SCIENCES INC
stock OTC

EOD
Aug 7, 2026
0.0110USD+10.000%(+0.0010)116,767
Pre-market
0.00USD-100.000%(-0.01)0
After-hours
0.00USD0.000%(0.00)0
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 18, 2022
05:22AM EST  EMMA: Easing Suffering from Sickle Cell Disease   Benzinga
Jan 4, 2022
08:23AM EST  Emmaus Life Sciences to Present at the H.C. Wainwright BioConnect Conference   PR Newswire
Dec 20, 2021
08:35AM EST  Life Sciences Companies Investor Presentations Now Available for On-Demand   PR Newswire
Dec 14, 2021
08:27AM EST  Emmaus Life Presents Positive Transfusion Data From Phase 3 Study Of Endari In Patients With Sickle Cell Disease   RTTNews
08:23AM EST  Analysis of its Phase 3 Clinical Study of Endari(r) in Patients With Sickle Cell Disease at the 63rd American Society of Hematology (ASH) Annual Meeting   PR Newswire
Dec 9, 2021
12:20PM EST  Life Sciences Virtual Investor Conference: Company Executives Present Live   PR Newswire
08:35AM EST  Emmaus Life Sciences to Webcast Live at Life Sciences Investor Forum on   PR Newswire
Dec 6, 2021
08:23AM EST  Emmaus Life Sciences' Data on Endari(r) Accepted for Poster Presentation at the   PR Newswire
Nov 12, 2021
08:23AM EST  Emmaus Life Sciences Reports Third Quarter Financial Results and Business   PR Newswire
Nov 11, 2021
08:23AM EST  Emmaus Life Sciences Announces Partnership with UpScript to Provide Telehealth   PR Newswire
Nov 4, 2021
08:23AM EDT  Emmaus Life Sciences Enters into Agreement with Asembia to Provide Expanded   PR Newswire
Oct 26, 2021
08:27AM EDT  Emmaus Life Sciences Submits Application For U.A.E. Marketing Authorization For Endari   RTTNews
08:23AM EDT  Emmaus Life Sciences Submits Application for U.A.E. Marketing Authorization for   PR Newswire
Oct 12, 2021
08:23AM EDT  Emmaus Life Sciences Acquires Key Intellectual Property Rights to Novel IRAK4   PR Newswire
Sep 8, 2021
07:01AM EDT  OTC Markets Group Welcomes Emmaus Life Sciences, Inc. to OTCQX   PR Newswire
Sep 2, 2021
08:45AM EDT  Emmaus Life Sciences Reports Financial Results for the Six Months Ended June   PR Newswire
Aug 17, 2021
08:45AM EDT  Emmaus Life Sciences Announces Bahrain Temporary License of Endari(r)   PR Newswire
Aug 10, 2021
08:45AM EDT  Emmaus Life Sciences Provides SEC Reporting Update   PR Newswire
Jul 22, 2021
09:01AM EDT  Emmaus Life Sciences Provides Interim Sales Information   PR Newswire
Jul 15, 2021
09:09AM EDT  Emmaus Life Sciences Announces Submission Of Endari MAA In Kuwait   RTTNews
09:04AM EDT  Emmaus Life Sciences Announces Submission of Endari(r) Marketing Authorization   PR Newswire
Jun 15, 2021
11:22AM EDT  Application to Swissmedic Ideogen, A.G. to Manage Early Access Program   PR Newswire
May 26, 2021
12:20PM EDT  Emmaus Life Sciences Announces Submission of Marketing Authorization   PR Newswire
May 4, 2021
09:31AM EDT  Emmaus Life Sciences Reports Annual Financial Results for 2020 and Provides   PR Newswire
Apr 15, 2021
02:17PM EDT  Emmaus Life Sciences Provides Form 10-K Filing Update   PR Newswire
Mar 2, 2021
11:45AM EST  Preclinical Development of IRAK4 Inhibitor as Potential Anti-Cancer Drug   PR Newswire
Jan 27, 2021
11:31AM EST  Emmaus Life Sciences Reports Increase in Sales Volume in 2020   PR Newswire
Jan 25, 2021
12:14PM EST  Emmaus Life Sciences Reports Annual Financial Results for 2019 and Provides   PR Newswire
Dec 10, 2020
11:31AM EST  Michigan Revises Prior Authorization Criteria for Endari(r)   PR Newswire
Dec 8, 2020
11:30AM EST  Emmaus Life Sciences Launches Endari(r) Support Program   PR Newswire
Dec 3, 2020
11:20AM EST  Endari(r) Granted Orphan Drug Status in Switzerland   PR Newswire
Nov 10, 2020
11:25AM EST  Emmaus Life Sciences Submits Temporary License Application in Bahrain for   PR Newswire
Nov 3, 2020
11:31AM EST  FDA Approves Updated Label for Endari(r)   PR Newswire
Oct 14, 2020
11:20AM EDT  Emmaus Life Sciences Announces the Sale of its Telcon RF Pharmaceutical Inc.   PR Newswire
Sep 1, 2020
08:00AM EDT  Emmaus Life Sciences Announces Informational Stockholders Meeting   GlobeNewswire Inc
Aug 18, 2020
01:41PM EDT  UPDATE - Emmaus Life Sciences Announces Submission of Marketing   GlobeNewswire Inc
08:00AM EDT  Emmaus Life Sciences Announces Submission of Marketing   GlobeNewswire Inc
Aug 5, 2020
08:00AM EDT  --Interim Analysis Indicates Decreased Number of Diverticula and Healthy Tissue--   GlobeNewswire Inc
Jul 31, 2020
08:00AM EDT  Emmaus Life Sciences Provides Additional Operational and OTC   GlobeNewswire Inc
Jul 29, 2020
12:10PM EDT  Emmaus Life Sciences Receives Scientific Advice From the EMA   GlobeNewswire Inc
Jul 23, 2020
01:14PM EDT  Emmaus Life Sciences Accelerates Middle East and North Africa   GlobeNewswire Inc
Jul 16, 2020
08:00AM EDT  Emmaus Life Sciences Announces Engagement of Partner International   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC